Foot tumor and diffuse pain: A case of oncogenic osteomalacia;Tumeur du pied et douleurs diffuses: Un cas d'ostéomalacie oncogénique

Annales de Pathologie

Volumn 25, Issue 2, 2005, Pages 134-137

  Poizat, Flora ^a   Wojtusciszin, Anne ^b   Raynaud, Pierre ^a   Maître, Hélène ^a   Renard, Éric ^b   Baldet, Pierre ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b Service de Maladies Métaboliques et Endocriniennes   (France)

Author keywords

FGF 23; Mesenchymal tumor; Oncogenic osteomalacia

Indexed keywords

FIBROBLAST GROWTH FACTOR 23;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FOOT DISEASE; FOOT PAIN; HUMAN; HUMAN TISSUE; MALE; OSTEOMALACIA;

EID: 22944457913     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(05)86176-0     Document Type: Article

References (4)

1. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004; 28: 1-30.
2. Nelson AE, Bligh RC, Mirams M, Gill A, Au a, Clarkson A et al. Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 2003; 88: 4088-94.
3. Prader A, Illig R, Uehlinger E, Stalder G. Rickets following bone tumor. Helv Paediatr Acta 1959; 14: 554-65.
4. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 1987; 59: 1442-54.